Actinomyces: Difference between revisions

	Actinomyces Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Actinomyces from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
X Ray
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Actinomyces On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Actinomyces All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Actinomyces
CDC on Actinomyces
Actinomyces in the news
Blogs on Actinomyces
Directions to Hospitals Treating Actinomyces
Risk calculators and risk factors for Actinomyces

Revision as of 14:32, 24 September 2012

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

@@ Line 5: / Line 5: @@
 {{Actinomyces}}
-==Diagnosis==
-Consider actinomycosis when the patient has chronic progression of disease across tissue planes that is mass-like at times, sinus tract development that may heal and recur, and refractory infection after a typical course of antibiotics.<ref name=El Sahli_2007>El Sahli, MD, MS.  "Anaerobic Pathogens." ''Infectious Disease Module 2007.''  Baylor College of Medicine, 2007.</ref>
 ==References==